Sandoz Group company profile

SDZ · SIX · CHF

Compare Sandoz Group
CHF 83.00Change from previous close: −1.89%Absolute change: −CHF 1.60

Close · November 17, 2026

Company profile

Sandoz Group has 20,000 employees and is headquartered in Basel, Switzerland.

Sold worldwide, the generic and biosimilar medicines of Sandoz Group AG are developed, manufactured and marketed by the company across a wide range of therapeutic areas, including oncology, cardiovascular and central nervous system disorders, immunology, diabetes and ophthalmology. Its therapeutic coverage also extends to hematology, nephrology, neurology and endocrinology. Its offering includes active pharmaceutical ingredients and finished dosage forms. A strategic collaboration with Shanghai Henlius Biotech aims to broaden patient access to biosimilar medicines.

In the fiscal year ended December 2025, revenue reached 11.2 billion US dollars, up 7.4% from the prior year, and net income came to 914 million US dollars. The company employs 20,000 people and is headquartered in Basel, Switzerland, where it was founded in 1886.

Company facts

Industry
Drug Manufacturers - Specialty & Generic
Headquarters
Centralbahnstrasse 4, 4051, Basel
Employees
20,000
Chief executive
Richard Saynor
Founded
1886
Fiscal year
January - December
Listing
SDZ · SIX
Indices
SMI
Currency
CHF
ISIN
CH1243598427
Website
sandoz.com

Sandoz Group and its competitors

The most similar companies by business and size

CompanyCountryMarket capEmployeesOperating marginP/E (trailing 12 months)
Sandoz GroupSDZSwitzerland$43.57B20,0009.3%72.3
HaleonHLNUnited Kingdom$40.15B24,53523.5%19.3
Galderma GroupGALDSwitzerland$51.94B7,67619.1%64.5
MerckMRKGermany$71.52B61,94917.0%33.9
Swedish Orphan BiovitrumSOBISweden$16.27B2,20730.9%25.0
IpsenIPNFrance$14.2B5,53527.4%25.5

Competitors: same or related industry, same region first, then the closest market capitalization. Market cap converted into US dollars at the latest exchange rates; P/E over the last 12 months, not shown when negative.

Compare Sandoz Group with its competitors